PGT-A Litigation

Lawsuits Representing Patients Who Have Undergone PGT-A Testing of Embryos

The IVF industry has a constant flow of new people who really want to build families and are sometimes desperate to do so. There is extraordinary potential for exploitation and wrongdoing. Recent filings in New Jersey, California, and Illinois identify PGT-A (preimplantation genetic testing for aneuploidies) testing as the most recent and perhaps most widespread example of fraud within IVF. The suits are supported by considerable evidence that PGT-A tests are inaccurate and based on false assumptions. PGT-A testing practices fail to disclose inherent risks associated with PGT-A, including the potential for misdiagnosis and the risk of embryo damage during biopsy. PGT-A may decrease the chance of having a baby as it often reduces the number of embryos available for transfer.

Potter Handy LLP is currently reviewing cases on behalf of individuals who have had their embryos tested for preimplantation genetic testing for aneuploidies (PGT-A). We believe there could be thousands of intended parents adversely impacted by fraudulent advertising, false assumptions, and inaccurate test results. Our firm will conduct a complimentary assessment of your claim to safeguard the rights and privacy of those impacted by current genetic testing practices.

To find out if you are eligible for compensation, please provide the information in the form below.

First Name *

Last Name *

Phone *

Email Address *

Address *

What state do you live in? *

What city do you live in? *

ZIP Code *

Please enter your date of birth (mm/dd/yyyy) *

Which testing company performed the PGT-A testing? *

How did you hear about Potter Handy? *

Tell us about your case *

Declaration *

By checking this box, I confirm that I am over 18 years of age and have reviewed and accepted the the Terms of Use and Privacy Policy of PotterHandy, LLP. I affirm that I have provided a true and accurate email address and phone number, and I acknowledge that this information will be used to contact me via email, phone, and text message, including SMS - regardless of my current standing in the "Do not call" registry. I understand that if my contact information is invalid or unmonitored, my request to participate in this litigation may be revoked. I also affirm that this is my first and only submission for inclusion in this litigation, and I will not resubmit this information later. Furthermore, I consent to the disclosure of my information to legal and non-legal service providers, partners, affiliates, and service providers. I agree to receive communications from Potter Handy, LLP, and its partners, including human and AI-driven messages, and understand that my agreement to receive these messages is voluntary. If I choose not to receive communications, I will opt out where applicable or not submit this request.

Disclaimer: Information provided to you through the Site and its Applications should not be regarded as medical or healthcare advice, diagnosis, or treatment. Always seek the advice of your physician, embryologist or other qualified healthcare provider with any questions you may have regarding fertility, embryology, a medical condition, start or terminating a course of treatment, or other health related issues. The decision of whether to test your embryos is one each patient should discuss with their doctor, with the full benefit of their unbiased and fully informed medical opinion. Potter Handy LLP is a law firm. We do not have specialized medical knowledge, and do not intend our advertising or the content of this site to be construed as medical advice.